Back to search results

PRESTO Study: Remote Exercise for Cardiovascular Health

This study, called PRESTO, is looking at different ways to help people at risk for heart disease (cardiovascular disease or CVD) become more active. You might be eligible if you are over 45, have risk factors like high blood pressure or diabetes, and aren't currently meeting physical activity guidelines. The study will compare in-person supervised exercise, live-streamed virtual classes, and self-directed exercise using apps like Myzone or MapMyFitness. Researchers want to see how well these methods work to increase your physical activity and improve your heart health over 12 weeks. They also want to understand what makes these programs easy or hard to stick with. The main goal is to measure your average minutes of moderate to vigorous physical activity each week.

Study design
This is an interventional study with a planned enrollment of 30 participants. It is not specified if participants will be randomly assigned to different exercise groups.
What's involved
Participants will engage in exercise sessions 3-5 times per week for 12 weeks, depending on the specific exercise program they are assigned to.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint for measuring physical activity is up to 13 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06931470

A Pilot Feasibility and Acceptability Study of Remote ExerciSe Training mOdalities (PRESTO)

Recruiting
NAAges 45+InterventionalPrevention
NYU Langone Health
~30 participants
Updated 2026-03-05 on ClinicalTrials.gov
What's tested:In-person supervised exercise sessionsVirtual classes (live-streamed sessions)Self-directed aerobic exerciseMyzone mobile applicationMap My Fitness mobile applicationCentralized telemetry

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Average minutes of moderate to vigorous physical activity per week
Measured over Up to 13 weeks

Conditions

Cardiovascular Diseases

Explore related trials

Cardiovascular Disorder

Where it's being run

1 sites across 1 states
New York1

Study leadership

  • Sean P. Heffron, MD · PRINCIPAL_INVESTIGATOR · NYU Langone Health

Who to contact

Sean Heffron, MD
[email protected]
857-366-1417
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Hypertension:
Systolic BP ≥140 mm Hg and/or diastolic BP ≥90 mm Hg and/or
Use of anti-hypertensive medication
Hyper / dyslipidemia
LDL cholesterol levels ≥160 mg/dL and/or
HDL cholesterol \<50mg/dL for women, \<40mg/dL for women, in addition to fasting triglycerides \>150mg/dL
Diabetes Mellitus:
Hemoglobin A1c levels ≥6.5%, fasting glucose levels ≥126 mg/dL, or 2-hour glucose levels ≥200 mg/dL after an oral glucose tolerance test and/or
Use of any diabetes medication
Smoking:
Obesity:
Family History of Premature Cardiovascular Disease:
Having a first-degree relative (parent, sibling) who developed CVD before age 55 for biological males or age 65 for biological females.

What this trial measures

  • Average minutes of moderate to vigorous physical activity per weekUp to 13 weeks

    Outcome is measured via wearable technology (smart device).